(NASDAQ: SYBX) Synlogic's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.31%.
Synlogic's earnings in 2024 is -$44,203,000.On average, 1 Wall Street analyst forecast SYBX's earnings for 2024 to be -$31,696,455, with the lowest SYBX earnings forecast at -$31,696,455, and the highest SYBX earnings forecast at -$31,696,455. On average, 1 Wall Street analyst forecast SYBX's earnings for 2025 to be -$5,497,171, with the lowest SYBX earnings forecast at -$5,497,171, and the highest SYBX earnings forecast at -$5,497,171.
In 2026, SYBX is forecast to generate -$2,690,105 in earnings, with the lowest earnings forecast at -$2,690,105 and the highest earnings forecast at -$2,690,105.